GlassScriptPhysician profile
Gemma Gulati
NPI 1932561388
$1,436.17
in general payments reported to CMS, 2019-2025
12 companies · $268 in 2025
The $268 reported for 2025 was more than what 81% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $89.89 · 2021: $175 · 2022: $91.99 · 2023: $200 · 2024: $612 · 2025: $268.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,080.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,079.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $216.37 | 2024 | Fasenra |
| Inari Medical, INC. | $175.60 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Zoll Respicardia, INC. | $174.30 | 2024 | Remede System |
| Philips North America LLC | $172.07 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $153.18 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $147.24 | 2025 | Wavewriter Alpha Prime 16 |
| Jazz Pharmaceuticals INC. | $126.99 | 2021 | |
| Axsome Therapeutics, INC. | $121.13 | 2025 | Symbravo |
| Inspire Medical Systems, INC. | $88.50 | 2023 | Inspire |
| Insmed, INC. | $27.02 | 2024 | Arikayce |
| Baxter Healthcare | $18.29 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Alexion Pharmaceuticals, INC. | $15.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gemma Gulati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.